These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27259901)

  • 21. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB; Goldberg B
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization of the HIV infected traveller.
    Chadwick DR; Geretti AM
    AIDS; 2007 Apr; 21(7):787-94. PubMed ID: 17415033
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 24. From the Centers for Disease Control and Prevention. Health Information for International Travel 1995.
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):62-3. PubMed ID: 11361475
    [No Abstract]   [Full Text] [Related]  

  • 25. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
    Jacobson MA; French M
    AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1999: treatments, issues to watch.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1-3. PubMed ID: 11366149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A; Cooper DA
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract]   [Full Text] [Related]  

  • 28. Discussion on the effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults.
    Thiébaut R; Eholié S; Dabis F
    AIDS; 2013 Jan; 27(1):146-7. PubMed ID: 23221429
    [No Abstract]   [Full Text] [Related]  

  • 29. Does Pneumocystis carinii prophylaxis still need to be lifelong?
    Masur H; Kaplan J
    N Engl J Med; 1999 Apr; 340(17):1356-8. PubMed ID: 10219072
    [No Abstract]   [Full Text] [Related]  

  • 30. Opportunistic infections in the era of highly active antiretroviral therapy.
    Ferri RS
    Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517
    [No Abstract]   [Full Text] [Related]  

  • 31. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
    Fichtenbaum CJ
    Res Initiat Treat Action; 1998 Jul; 4(4):3-7. PubMed ID: 11365645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on travellers and HIV/AIDS.
    Can Commun Dis Rep; 1994 Sep; 20(17):147-9. PubMed ID: 7812232
    [No Abstract]   [Full Text] [Related]  

  • 33. Withdrawal of Pneumocystis prophylaxis.
    Zingman BS; Grossberg R
    AIDS; 2008 Jan; 22(2):323-4; author reply 324. PubMed ID: 18097244
    [No Abstract]   [Full Text] [Related]  

  • 34. Opportunistic infections...is it safe to stop prophylaxis?
    Highleyman L
    BETA; 1999 Jan; 12(1):33-41. PubMed ID: 11367237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
    Currier JS
    AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preaching what we practice: new guidelines for OI prophylaxis.
    Feinberg J
    AIDS Clin Care; 1999 Nov; 11(11):87-9, 94. PubMed ID: 11366709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should we be stopping opportunistic infection prophylaxis in the era of HAART?
    Fisher M
    J Infect; 1998 May; 36(3):iv. PubMed ID: 9661931
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunopathogenesis of mycobacterial immune restoration disease.
    French MA
    Lancet Infect Dis; 2006 Aug; 6(8):461-2. PubMed ID: 16870523
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immune reconstitution syndrome. A new disease in HIV-infected patients effectively treated with antiretroviral drugs].
    Stoll M; Behrens GM; Schmidt RE
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1017-22. PubMed ID: 11555777
    [No Abstract]   [Full Text] [Related]  

  • 40. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.